Mycobacterium fortuitum-induced persistent parotitis: Successful therapy with clarithromycin and ciprofloxacin

Head and Neck

Volumn 29, Issue 11, 2007, Pages 1061-1064

  Chen, Chien Cheng ^a   Chen, Shiou Yi ^a   Chen, Yun Sung ^a   Lo, Cheng Yu ^a   Cheng, Po Wen ^a  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Ciprofloxacin; Clarithromycin; Mycobacterium fortuitum; Nontuberculous mycobacteria; Parotitis

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMYLASE; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; ANTIINFECTIVE AGENT;

AMYLASE BLOOD LEVEL; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE DURATION; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENZYME ACTIVITY; FACE PAIN; FEMALE; FOLLOW UP; GRANULOMATOUS INFLAMMATION; HISTOPATHOLOGY; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM FORTUITUM; PAROTID ENLARGEMENT; PAROTITIS; PERSISTENT INFECTION; PRIORITY JOURNAL; RADIODIAGNOSIS; SCHOOL CHILD; TREATMENT DURATION; TREATMENT OUTCOME; ATYPICAL MYCOBACTERIOSIS; CHILD; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; CHILD; CIPROFLOXACIN; CLARITHROMYCIN; FEMALE; HUMANS; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS, ATYPICAL; PAROTITIS;

EID: 39749159185     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20626     Document Type: Article

References (18)

1. Rieu PN, van den Broek P, Pruszczynski M, de Wilde PC, Festen C. Atypical mycobacterial infection of the parotid gland. J Pediatr Surg 1990;25:483-486.
2. Clegg HW, Bertagnoll P, Hightower AW, Baine WB. Mammaplasty-associated mycobacterial infection: a survey of plastic surgeons. Plast Reconstr Surg 1983;72:165-169.
3. Smith MB, Schnadig VJ, Boyars MC, Woods GL. Clinical and pathologic features of Mycobacterium fortuitum infections. An emerging pathogen in patients with AIDS. Am J Clin Pathol 2001;116:225-232.
4. Butt AA. Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome. Am J Med Sci 1998;315:50-55.
5. Brown T. The rapidly growing mycobacteria-Mycobacterium fortuitum and Mycobacterium chelonei. Infect Control 1985;6:283-288.
6. Heistein JB, Mangino JE, Ruberg RL, Bergese JJ. A prosthetic breast implant infected with Mycobacterium fortuitum. Ann Plast Surg 2000;44:330-333.
7. Raad II, Vartivarian S, Khan A, Bodey GP. Catheter related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991;13:1120-1125.
8. Dugel PU, Holland GN, Brown HH, et al. Mycobacterium fortuitum keratitis. Am J Ophthalmol 1988;105:661-669.
9. Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993;16:463-471.
10. Schaad UB, Votteler TP, McCracken GH Jr, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr 1979;95:356-360.
11. Suskind DL, Handler SD, Tom LW, Potsic WP, Wetmore RF. Nontuberculous mycobacterial cervical adenitis. Clin Pediatr 1997;36:403-409.
12. Robson CD. Imaging of granulomatous lesions of the neck in children. Radiol Clin North Am 2000;38:969-977.
13. Hazra R, Robson CD, Perez-Atayde AR, Husson RN. Lymphadenitis due to nontuberculous mycobacteria in children: presentation and response to therapy. Clin Infect Dis 1999;28:123-129.
14. Woods GL, Washington JA II. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 1987;9:275-294.
15. Stanley RB, Fernandez JA, Peppard SB. Cervicofacial mycobacterial infections presenting as major salivary gland disease. Laryngoscope 1983;93:1271-1275.
16. Stewart MG, Starke JR, Coker NJ. Nontuberculous mycobacterial infections of the head and neck. Arch Otolaryngol Head Neck Surg 1994;120:873-876.
17. Brown BA, Wallace RJ Jr, Onyi GO, De Rosas V, Wallace RJ III. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180-184.
18. Rapp RP, McCraney SA, Goodman NL, Shaddick DJ. New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis. Ann Pharmacother 1994;28:1255-1263.